|
1. BIO president visits, lauds North Carolina's efforts.
Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), visited North Carolina Nov. 14 for the first time since becoming head of the ... (PREMIUM PERIODICAL ARTICLE)
2. Five questions for Christopher Price.
The Piedmont Triad Research Park in Winston-Salem is expanding with new projects ranging from opening a new 177,000-square-foot biotechnology research building in 2006 to developing ... (PREMIUM PERIODICAL ARTICLE)
3. Three more Biotech Forums remain.(Calendar)
The 2005-06 Biotech Forum season continues with three more events scheduled through May at the Charles Hamner Conference Center of the North Carolina Biotechnology Center, ... (PREMIUM PERIODICAL ARTICLE)
4. Chaffee, Johnson take reigns in East, Southeast.
Two prominent economic development executives began work Jan. 3, 2006, as directors of the North Carolina Biotechnology Center's new Eastern and Southeastern regional offices. John ... (PREMIUM PERIODICAL ARTICLE)
5. Biotech 2006 conference heads to Winston-Salem.
For the first time in its 15-year history, the Council for Entrepreneurial Development's annual biotechnology showcase will be held outside of the Triangle. Winston-Salem will ... (PREMIUM PERIODICAL ARTICLE)
6. Kannapolis residents ponder job possibilities with research campus.
KANNAPOLIS--Minutes after California billionaire David Murdock unveiled plans in September to build the 350-acre North Carolina Research Campus in the city, a middle-aged man climbed ... (PREMIUM PERIODICAL ARTICLE)
7. Economic Development Summit draws 100 people.
Economic developers from throughout North Carolina learned about biotechnology opportunities at a daylong Life Science Economic Development Summit sponsored Dec. 8 by the Biotechnology Center ... (PREMIUM PERIODICAL ARTICLE)
8. Online industry directory undergoing changes.
The North Carolina Biotechnology Center is revamping its popular online directory of the state's biotechnology industry (BioSciNC) to make it more user friendly. The changes ... (PREMIUM PERIODICAL ARTICLE)
9. Collaborations.(Biotechnology Community Watch)
TransTech of High Point and Boehringer Ingelheim GmbH of Germany signed a research and license agreement to discover and develop novel small molecules. The deal ... (PREMIUM PERIODICAL ARTICLE)
10. Venture capital.(Biotechnology Community Watch)
Aerie Pharmaceuticals of Research Triangle Park landed $21 million in venture capital led by Alta Partners and Texas Pacific Group Ventures. CeNeRx BioPharma of Cary ... (PREMIUM PERIODICAL ARTICLE) | |
|
1-10 (of 11) related articles
Items per page
1-10 (of 11) related articles
|